Phenotypic overlap between MMP-13 and the plasminogen activation system during wound healing in mice

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Juncker Jensen, Anna ^a   Lund, Leif R ^a,b  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CYTOKERATIN 10; CYTOKERATIN 14; PLASMINOGEN; MMP13 PROTEIN, MOUSE; PLASMINOGEN ACTIVATOR; UROKINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME DEFICIENCY; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PLASMINOGEN ACTIVATION; POSTNATAL DEVELOPMENT; PREGNANCY; SKIN INJURY; SKIN SURFACE; WILD TYPE; WOUND HEALING; ANIMAL; GENETICS; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN DISEASE; SURVIVAL;

MUS;

ANIMALS; FEMALE; MALE; MATRIX METALLOPROTEINASE 13; MICE; MICE, KNOCKOUT; PHENOTYPE; PLASMINOGEN; PLASMINOGEN ACTIVATORS; PREGNANCY; SIGNAL TRANSDUCTION; SKIN DISEASES; SURVIVAL; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 79951532241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016954     Document Type: Article

References (58)

1. Affara NI, Andreu P, Coussens LM, (2009) Delineating protease functions during cancer development. Methods Mol Biol 539: 1-32.
2. Almholt K, Juncker-Jensen A, Green KA, Solberg H, Lund L, et al. (2009) The plasminogen Aativation system in tissue remodelling and cancer invasion. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF, editors. The Cancer Degradome Springer New York pp. 203-221.
3. Deryugina EI, Quigley JP, (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34.
4. Lemaitre V, D'Armiento J, (2006) Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today 78: 1-10.
5. Lund LR, Romer J, Thomasset N, Solberg H, Pyke C, et al. (1996) Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and-dependent pathways. Development 122: 181-193.
6. Page-McCaw A, Ewald AJ, Werb Z, (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221-233.
7. Toriseva M, Kahari VM, (2009) Proteinases in cutaneous wound healing. Cell Mol Life Sci 66: 203-224.
8. Nagase H, Visse R, Murphy G, (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573.
9. Cauwe B, Van den Steen PE, Opdenakker G, (2007) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42: 113-185.
10. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G, (1996) Biochemical characterization of human collagenase-3. J Biol Chem 271: 1544-1550.
11. Ala-aho R, Kahari VM, (2005) Collagenases in cancer. Biochimie 87: 273-286.
12. Cazorla M, Hernandez L, Nadal A, Balbin M, Lopez JM, et al. (1998) Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 186: 144-150.
13. Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, et al. (1997) Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 151: 499-508.
14. Dano K, Behrendt N, Hoyer-Hansen G, Johnsen M, Lund LR, et al. (2005) Plasminogen activation and cancer. Thromb Haemost 93: 676-681.
15. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139-266.
16. Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, et al. (2006) Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J 25: 2686-2697.
17. Zijlstra A, Aimes RT, Zhu D, Regazzoni K, Kupriyanova T, et al. (2004) Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3). J Biol Chem 279: 27633-27645.
18. Bugge TH, Flick MJ, Daugherty CC, Degen JL, (1995) Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9: 794-807.
19. Green KA, Almholt K, Ploug M, Rono B, Castellino FJ, et al. (2008) Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen. J Invest Dermatol 128: 2092-2101.
20. Mingers AM, Heimburger N, Zeitler P, Kreth HW, Schuster V, (1997) Homozygous type I plasminogen deficiency. Semin Thromb Hemost 23: 259-269.
21. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, et al. (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368: 419-424.
22. Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, et al. (2008) Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China. Oncology 75: 49-59.
23. Dano K, Romer J, Nielsen BS, Bjorn S, Pyke C, et al. (1999) Cancer invasion and tissue remodeling-cooperation of protease systems and cell types. APMIS 107: 120-127.
24. Dvorak HF, (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659.
25. Schafer M, Werner S, (2008) Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 9: 628-638.
26. Airola K, Johansson N, Kariniemi AL, Kahari VM, Saarialho-Kere UK, (1997) Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 109: 225-231.
27. Lund LR, Romer J, Bugge TH, Nielsen BS, Frandsen TL, et al. (1999) Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 18: 4645-4656.
28. Madlener M, Parks WC, Werner S, (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 242: 201-210.
29. Romer J, Lund LR, Eriksen J, Ralfkiaer E, Zeheb R, et al. (1991) Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J Invest Dermatol 97: 803-811.
30. Romer J, Pyke C, Lund LR, Ralfkiaer E, Dano K, (2001) Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin. J Invest Dermatol 116: 353-358.
31. Netzel-Arnett S, Mitola DJ, Yamada SS, Chrysovergis K, Holmbeck K, et al. (2002) Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity. J Biol Chem 277: 45154-45161.
32. Gurtner GC, Werner S, Barrandon Y, Longaker MT, (2008) Wound repair and regeneration. Nature 453: 314-321.
33. Moali C, Hulmes DJ, (2009) Extracellular and cell surface proteases in wound healing: new players are still emerging. Eur J Dermatol 19: 552-564.
34. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, et al. (1996) Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2: 287-292.
35. Saghatelian A, Jessani N, Joseph A, Humphrey M, Cravatt BF, (2004) Activity-based probes for the proteomic profiling of metalloproteases. Proc Natl Acad Sci U S A 101: 10000-10005.
36. Uttamchandani M, Wang J, Li J, Hu M, Sun H, et al. (2007) Inhibitor fingerprinting of matrix metalloproteases using a combinatorial peptide hydroxamate library. J Am Chem Soc 129: 7848-7858.
37. Chen P, Parks WC, (2009) Role of matrix metalloproteinases in epithelial migration. J Cell Biochem 108: 1233-1243.
38. Oh J, Takahashi R, Adachi E, Kondo S, Kuratomi S, et al. (2004) Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene 23: 5041-5048.
39. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, et al. (2004) Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131: 5883-5895.
40. Lambert V, Wielockx B, Munaut C, Galopin C, Jost M, et al. (2003) MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 17: 2290-2292.
41. Sternlicht MD, Werb Z, (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516.
42. Frossing S, Rono B, Hald A, Romer J, Lund LR, (2010) Skin wound healing in MMP2-deficient and MMP2/Plasminogen double-deficient mice. Exp Dermatol 19 (8): e234-240.
43. Hald A, Rono B, Melander MC, Ding M, Holck S, et al. (2010) MMP9 is protective against lethal inflammatory mass lesions in the mouse colon. Dis Model Mech [epub ahead of print].
44. Andreasen PA, Egelund R, Petersen HH, (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57: 25-40.
45. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, et al. (2007) Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 178: 5288-5295.
46. Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H, (2000) Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J Biol Chem 275: 33008-33013.
47. Hartenstein B, Dittrich BT, Stickens D, Heyer B, Vu TH, et al. (2006) Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J Invest Dermatol 126: 486-496.
48. Martin P, (1997) Wound healing-aiming for perfect skin regeneration. Science 276: 75-81.
49. Singer AJ, Clark RA, (1999) Cutaneous wound healing. N Engl J Med 341: 738-746.
50. Hattori N, Mochizuki S, Kishi K, Nakajima T, Takaishi H, et al. (2009) MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am J Pathol 175: 533-546.
51. Ogura Y, Matsunaga Y, Nishiyama T, Amano S, (2008) Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. Br J Dermatol 159: 49-60.
52. Wahlgren J, Vaananen A, Teronen O, Sorsa T, Pirila E, et al. (2003) Laminin-5 gamma 2 chain is colocalized with gelatinase-A (MMP-2) and collagenase-3 (MMP-13) in odontogenic keratocysts. J Oral Pathol Med 32: 100-107.
53. Bullard KM, Lund L, Mudgett JS, Mellin TN, Hunt TK, et al. (1999) Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg 230: 260-265.
54. Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F, et al. (2002) Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 277: 2065-2072.
55. Rakic JM, Maillard C, Jost M, Bajou K, Masson V, et al. (2003) Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell Mol Life Sci 60: 463-473.
56. Tkachuk VA, Plekhanova OS, Parfyonova YV, (2009) Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. Can J Physiol Pharmacol 87: 231-251.
57. Almholt K, Lund LR, Rygaard J, Nielsen BS, Dano K, et al. (2005) Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice. Int J Cancer 113: 525-532.
58. Nielsen BS, Egeblad M, Rank F, Askautrud HA, Pennington CJ, et al. (2008) Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression. PLoS One 3: e2959.